INT84811

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.51
First Reported 1999
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 6
Total Number 8
Disease Relevance 2.65
Pain Relevance 2.74

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (Ado)
Anatomy Link Frequency
plasma 3
Ado (Rattus norvegicus)
Pain Link Frequency Relevance Heat
adenocard 59 100.00 Very High Very High Very High
agonist 7 100.00 Very High Very High Very High
antinociception 1 99.48 Very High Very High Very High
Thermal hyperalgesia 5 98.28 Very High Very High Very High
Antihyperalgesic 2 88.72 High High
anesthesia 3 80.20 Quite High
noradrenaline 15 75.76 Quite High
antagonist 2 74.48 Quite High
Antinociceptive 2 71.84 Quite High
transdermal 3 63.04 Quite High
Disease Link Frequency Relevance Heat
Patent Ductus Arteriosus 147 99.98 Very High Very High Very High
Hyperalgesia 5 98.28 Very High Very High Very High
Bacterial Endocarditis 30 94.08 High High
Cv General 4 Under Development 3 91.96 High High
Cv Unclassified Under Development 8 86.20 High High
Increased Venous Pressure Under Development 6 81.24 Quite High
Fever 27 79.44 Quite High
Hemolysis 48 66.28 Quite High
Coagulation Disorder 3 48.00 Quite Low
Renal Failure 3 47.32 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The possibility was investigated that CPT-induced increases in plasma ADO levels were not only an expression of the increased production of ADO in the ischaemic area, but also a consequence of systemic sympathoexcitatory mechanisms, thus showing a bidirectional involvement of the mechanisms of ADO formation. 2.
Gene_expression (expression) of ADO in plasma associated with adenocard
1) Confidence 0.51 Published 1999 Journal Clin. Exp. Pharmacol. Physiol. Section Abstract Doc Link 10549400 Disease Relevance 0.17 Pain Relevance 0.47
The possibility was investigated that CPT-induced increases in plasma ADO levels were not only an expression of the increased production of ADO in the ischaemic area, but also a consequence of systemic sympathoexcitatory mechanisms, thus showing a bidirectional involvement of the mechanisms of ADO formation. 2.
Gene_expression (production) of ADO in plasma associated with adenocard
2) Confidence 0.45 Published 1999 Journal Clin. Exp. Pharmacol. Physiol. Section Abstract Doc Link 10549400 Disease Relevance 0.17 Pain Relevance 0.48
The possibility was investigated that CPT-induced increases in plasma ADO levels were not only an expression of the increased production of ADO in the ischaemic area, but also a consequence of systemic sympathoexcitatory mechanisms, thus showing a bidirectional involvement of the mechanisms of ADO formation. 2.
Gene_expression (expression) of ADO in plasma associated with adenocard
3) Confidence 0.45 Published 1999 Journal Clin. Exp. Pharmacol. Physiol. Section Abstract Doc Link 10549400 Disease Relevance 0.17 Pain Relevance 0.48
Unlike the AK inhibitors, however, these ADO receptor agonists produced significant antinociception only at doses that also decreased motor performance.
Gene_expression (produced) of ADO associated with antinociception, adenocard and agonist
4) Confidence 0.42 Published 2002 Journal Pharmacol. Biochem. Behav. Section Abstract Doc Link 12151032 Disease Relevance 0.37 Pain Relevance 1.22
On the basis of ductal morphology and size, interventional occlusions were conducted with ADO (97 patients), Cook detachable coil (15 patients), Nit-Occlud coil (4 patients), or a buttoned device combined with a Cook detachable coil (1 patient).
Gene_expression (conducted) of ADO
5) Confidence 0.25 Published 2007 Journal Journal of Korean Medical Science Section Body Doc Link PMC2693642 Disease Relevance 0.42 Pain Relevance 0.08
Her PDA was closed using a 12/10 mm ADO.
Gene_expression (closed) of ADO associated with patent ductus arteriosus
6) Confidence 0.25 Published 2007 Journal Journal of Korean Medical Science Section Body Doc Link PMC2693642 Disease Relevance 0.68 Pain Relevance 0
Transcatheter occlusion of large PDA using ADO has been proved highly efficacious in large series (5, 13).
Gene_expression (using) of ADO associated with patent ductus arteriosus
7) Confidence 0.25 Published 2007 Journal Journal of Korean Medical Science Section Body Doc Link PMC2693642 Disease Relevance 0.58 Pain Relevance 0
Dogs (n=6 per group) received unsupplemented BCP, ADO (100 micromol/L/L) supplemented in all infusions of BCP (ADO-CP), or ADO (100 micromol x L(-1) x L(-1)) supplemented only in the terminal infusion of BCP followed by intravenous ADO (140 microg x kg(-1) x min(-1)) infusion for the first 30 minutes of reperfusion (ADO-R).
Gene_expression (received) of ADO
8) Confidence 0.04 Published 1999 Journal Circulation Section Body Doc Link 10567333 Disease Relevance 0.09 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox